Novel imidazo(1,5-a)pyridine derivatives, method for preparing same and pharmaceutical compositions containing same

Details for Australian Patent Application No. 2006224466 (hide)

Owner Sanofi-Aventis

Inventors Bono, Francoise; Alcouffe, Chantal; Bordes, Marie-Francoise; Badorc, Alain

Agent A J Park

Pub. Number AU-B-2006224466

PCT Pub. Number WO2006/097625

Priority 0502590 16.03.05 FR

Filing date 15 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 16 February 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/097625 Priority application(s): WO2006/097625

16 February 2012 Application Accepted

  Published as AU-B-2006224466

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224472-Method and device for isolating microorganisms

2006224465-7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3, 6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof